Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: Prospective cohort study

BMJ

Volumn 336, Issue 7647, 2008, Pages 754-757

  Pearce, Anna ^a   Law, Catherine ^a   Elliman, David ^b   Cole, Tim J ^a   Bedford, Helen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; HEALTH SURVEY; HUMAN; IMMUNIZATION; MEASLES; MEDICAL INFORMATION; MUMPS; PRIORITY JOURNAL; RISK FACTOR; RUBELLA; SOCIOECONOMICS; UNITED KINGDOM;

ADOLESCENT; ADULT; CHILD, PRESCHOOL; COHORT STUDIES; FAMILY CHARACTERISTICS; FEMALE; GREAT BRITAIN; HUMANS; IMMUNIZATION; MALE; MATERNAL AGE; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 41949107501     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39489.590671.25     Document Type: Article

References (20)

1. Communicable Disease Surveillance Centre. COVER/Komer July to September 1995. CDR Wkly (Online) 1995;5:301.
2. Wakefield A, Murch S, Anthony A, Linnell J, Casson D, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41.
3. Health Protection Agency. COVER programme: January to March 2003. CDR Wkly (Online) 2003;91:465-8.
4. Health Protection Agency. COVER programme: July to September 2007. Health Protection Report 2007;1(15).
5. Booy R, Sengupta N, Bedford H, Elliman D. Measles, mumps and rubella: prevention. Clin Evid 2006;15:1-3.
6. Demicheli V, Jefferson T, Rivetti A, Price D. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2005;(4):CD004407.
7. Cassell J, Leach M, Poltorak M, Mercer C, Iversen A, Fairhead J. Is the cultural context of MMR rejection a key to an effective public health discourse? Public Health 2006;120:783-94.
8. Casiday R, Cresswell T, Wilson D, Panter-Brick C. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine 2006;24:177-84.
9. Lamden K, Wragg A, Gomall S. MMR debate: how many children are actually receiving single vaccines? Commun Dis Public Health 2004;7:388-9.
10. Sonnenberg P, Crowcroft N, White J, Ramsay M. The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and Wales. Arch Dis Child 2007;92:786-9.
11. Sharland M, Atkinson P, Maguire H, Begg N. Lone parent families are an independent risk factor for lower rates of childhood immunisation in London. Commun Dis Rep CDR Rev 1997;7:R196-72.
12. Li J, Taylor B. Childhood immunisation and family size. Health Trends 2006;25:16-9.
13. Middleton E, Baker D. Comparison of social distribution of immunisation with measles, mumps, and rubella vaccine, England, 1991-2001. BMJ 2003;326:854.
14. Wright J, Polack C. Understanding variation in measles-mumps-rubella immunization coverage-a population based study. Eur J Public Health 2006;16:137-42.
15. Li J, Taylor B. Factors affecting uptake of measles, mumps, and rubella immunisation. BMJ 1993;307:168-71.
16. Friederichs V, Cameron J, Robertson C. Impact of adverse publicity on MMR vaccine uptake: a population based analysis of vaccine uptake records for one million children, born 1987-2004. Arch Dis Child 2006;91:465-8.
17. Hadjikoumi I, Niekerk K, Scott C. MMR catch up campaign: reasons for refusal to consent. Arch Dis Child 2006;91:621.
18. Centre for Longitudinal Studies. Millennium cohort study: survey design. Institute of Education. www.cls.ioe.ac.uk/studies.asp?section= 0001000200010010.
19. Speers T, Lewis J. Journalists and jabs: media coverage of the MMR vaccine. Community Med 2004;1:171-81.
20. Department of Health. NHS immunisation statistics, England: 2003-2004. London: DH, 2004.